000 01660nam a2200397 a 4500
001 0000166059
005 20171002063313.0
006 m u
007 cr cn|||||||||
008 100122s2010 nyuab sb 001 0 eng d
010 _z 2010002978
020 _z9781616682330 (softcover)
020 _z1616682337 (softcover)
020 _z9781616684785 (e-book)
035 _a(CaPaEBR)ebr10674883
035 _a(OCoLC)682621157
040 _aCaPaEBR
_cCaPaEBR
050 1 4 _aRM409
_b.V56 2010eb
082 0 4 _a615.5/8
_222
100 1 _aVinšová, Jarmila.
245 1 0 _aDevelopment of new MDR-tuberculosis drugs
_h[electronic resource] /
_cJarmila Vinšová and Martin Krátký.
260 _aNew York :
_bNova Science Publishers/Nova Biomedical,
_cc2010.
300 _axii, 98 p. :
_bill., map.
490 1 _aPharmacology-research, safety testing and regulation
504 _aIncludes bibliographical references and index.
505 0 _aResistance to commonly used drugs, mechanism of the action -- Research of novel MDR potential drugs.
533 _aElectronic reproduction.
_bPalo Alto, Calif. :
_cebrary,
_d2013.
_nAvailable via World Wide Web.
_nAccess may be limited to ebrary affiliated libraries.
650 0 _aAntitubercular agents.
650 0 _aMultidrug-resistant tuberculosis
_xChemotherapy.
655 7 _aElectronic books.
_2local
700 1 _aKrátký, Martin,
_d1960-
710 2 _aebrary, Inc.
830 0 _aPharmacology-research, safety testing, and regulation series.
856 4 0 _uhttp://site.ebrary.com/lib/daystar/Doc?id=10674883
_zAn electronic book accessible through the World Wide Web; click to view
908 _a170314
942 0 0 _cEB
999 _c155204
_d155204